Abstract:Background: S-adenosylmethionine (SAMe) is all endogenous molecule that plays an Important role in cellular metabolism. Despite being widely used as a dietary supplement with claimed benefits for numerous conditions', there is little Information about the pharmacokinetic properties of exogenous SAMe.Objectives: One aim of this study was to characterize the pharmacokinetic properties of SAMe after administration of single and Multiple doses of orally and intravenously administered SAMe tosylate disulfate (STD) in healthy male and female Chinese volunteers. Because men have higher erythrocyte levels of endogenous SAMe than do women, we also assessed the effects of sex on the disposition of SAMe.Methods: A simple and sensitive assay for SAMe based on liquid chromatography-mass spectrometry using selected-ion monitoring of analyte and acyclovir as internal standard was developed and validated. The assay was used to study the pharmacokinetic properties of SAMe. STD was administered as single and multiple doses of enteric-coated tablets and TV infusion of STD to groups of healthy native Chinese Volunteers. After an overnight fast, male and female Chinese volunteers were assigned to receive STD 1000 mg for 5 days, either in enteric-coated tablet formulation or as a 250-mL IV Infusion. Blood samples were collected 24 hours after the first and last dose and used for determining plasma SAMe concentrations and pharmacokinetic parameters. For the oral formulation, SAMe concentrations were corrected for concentrations of endogenous SAMe. Pharmacokinetic parameters were calculated for men and women separately and for the total group Of volunteers. Adverse events were monitored using a physician during blood collection and by spontaneous reporting.Results: Twenty health), Volunteers were enrolled (oral formulation: 5 men, 5 women; mean [SD] age, 24.1 [4.7] years [range, 21-37 years]; mean [SD] weight, 59.9 [4.8] kg [range, 54-70 kg]; IV formulation: 5 men, 5 women; mean [SD] age, 22.6 [1.8] years [range, 21-27 years]; mean [SD] weight, 59.5 [5.4] kg [range, 53-67 kg]). None of the between-sex differences in SAMe pharmacokinetic properties were significant. The (mean [SD]) pharmacokinetic properties of single-dose oral SAMe in men and women, respectively, were as follows: C-max, 2.37 (1.58) and 2.50 (1.83) mu mol/L; T-max, 5.40 (1.14) and 5.20 (1.48) hours; AUC(0-24), 8.56 (5.16) and 10.3 (8.0) mu mol/L/h; and t(1/2 beta), 6.06 (1.80) and 6.28 (2.60) hours. Corresponding, values with the single-dose IV formulation were: C-max, 127 (49) and 211 (94) mu mol/L; T-max, 1.90 (0.22) and 1.60 (0.22) hours; AUC(0-24), 329 (84) and 480 (176) mu mol/L/h; and t(1/2 beta), 4.34 (0.57) and 3.83 (0.78) hours. The single-dose oral:IV ratios of AUC(0-24) in men and women, respectively, were 2.60% and 2.14% (degrees of fluctuation: 4.96 [1.77] and 9.49 [0.91]). The pharmacokinetic properties of multiple-dose oral and IV SAMe were not significantly different from those with single-dose administration. None of the volunteers reported any adverse events during the study.Conclusions: In this small study in healthy Chinese volunteers, there were no significant differences in the pharmacokinetic parameters of SAMe between men and women or between single- and multiple-dose administration of STD 1000 mg administered orally or intravenously. No evidence of accumulation of SAW in plasma was found on multiple dosing. Both enteric-coated tablets and the IV infusion were well tolerated in these volunteers. (Clin Ther. 2009;31:311-320) (C) 2009 Excerpta Medica Inc.

S-Adenosylmethionine (SAMe) as an adjuvant therapy for patients with depression: An updated systematic review and meta-analysis

Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta- analysis

A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.

S-Adenosylmethionine (SAMe) for Central Nervous System Health: A Systematic Review

Antidepressant-Like Effects of Sanyuansan in the Mouse Forced Swim Test, Tail Suspension Test, and Chronic Mild Stress Model

The Efficacy of S-Adenosyl Methionine and Probiotic Supplementation on Depression: A Synergistic Approach

The protective effect of S-adenosylmethionine on chronic adolescent stress-induced depression-like behaviors by regulating gut microbiota

S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis

Efficacy and safety of Chinese patent medicines combined with antidepressants for treatment of depression in adults: A multiple-treatment meta-analysis

S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life

S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review

Meta-analysis of Acupuncture Combined with Paroxetine in the Treatment of Depression

Effects of S-Adenosylmethionine on Cognition in Animals and Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The Efficacy and Safety of Complementary and Alternative Medicine for Depression: An Umbrella Review

Efficacy and safety of repeated transcranial magnetic stimulation combined with escitalopram in the treatment of major depressive disorder: a meta-analysis

Chinese herbal medicines for the treatment of depression: a systematic review and network meta-analysis

Efficacy and safety of agomelatine and SSRIs or SNRIs treating depression: a Meta-analysis

A network meta-analysis on the effectiveness and safety of acupuncture in treating patients with major depressive disorder

Pharmacokinetic Properties of S-adenosylmethionine after Oral and Intravenous Administration of Its Tosylate Disulfate Salt: a Multiple-Dose, Open-Label, Parallel-Group Study in Healthy Chinese Volunteers.

Adjuvant Therapy of Oral Chinese Herbal Medicine for Menopausal Depression: A Systematic Review and Meta-Analysis

A Preliminary Study of Different Treatment Strategies for Anxious Depression.